QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes
... Corp. (Nasdaq: UTHR ) Valeant Pharmaceuticals Int'l (NYSE: VRX ) Vertex Pharmaceuticals (Nasdaq: VRTX ) Add Adolor Corp. (Nasdaq: ADLR ) allos THERAPEUTICS INC. (Nasdaq: ALTH ) Alnylam Pharmaceuticals Inc. (Nasdaq: ALNY ) Alpharma Inc. (NYSE: ALO ) Altus Pharmaceuticals Inc. (Nasdaq:...Allos Therapeutics Appoints Bruce K. Bennett as Vice President, Manufacturing
...iversity, Long Beach. "I am very excited to join allos and lead the Company's manufacturing activities," said Mr. Bennett. "I believe allos has the product candidates and leadership team to ...ew therapies for the treatment of cancer." About allos Therapeutics, Inc. ...Allos Therapeutics to Present at the 2007 RBC Capital Markets Healthcare Conference
...ch will be accessible through a link posted on the allos website home page and investor relations section. ... Allos' website through December 28, 2007. About allos Therapeutics, Inc. allos Therapeutics is a biopharmaceutical company focuse...Allos Therapeutics Reports Third Quarter 2007 Financial Results
...al 480-629-9562. Participants should reference the allos Therapeutics conference call. Conference Call Rep...llos.com and will be archived for 30 days. About allos Therapeutics, Inc. allos Therapeutics, Inc. (ALTH) is a biopharmaceutical c...Allos Therapeutics to Present at the 2007 Acumen BioFin Rodman & Renshaw Conference
...be available for replay on Allos' website through November 20, 2007. About allos Therapeutics, Inc. allos Therapeutics is a biopharmaceutical company focused on the development and ...William R. Ringo Joins Hyperion Therapeutics, Inc. Board of Directors as Chairman
...at Sofinnova Ventures and serves as Chairman of the Board of Directors at Intermune and a member of the Board of Directors of Inspire Pharmaceuticals, allos Therapeutics, Alvine Pharmaceuticals, Portola Pharmaceuticals, and BioCrossroads, a not for profit organization. Mr. Ringo holds a B.S. and an M.B.A. ...Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
...otrexate and certain other DHFR inhibitors. About allos Therapeutics, Inc. allos Therapeutics is a biopharmaceutical company focuse...resentation, except as required by law. Note: The allos logo is a trademark of...Allos Therapeutics' PDX Granted Orphan Medicinal Product Designation by the European Commission
...irst-line or relapsed or refractory PTCLs. About allos Therapeutics, Inc. allos Therapeutics, Inc. (ALTH) is a biopharmaceutical c...pt as required by law. Note: EFAPROXYNTM and the allos logo are trademarks of Allos Therapeutics, Inc. ...OncoMed Pharmaceuticals Appoints Sunil Patel Senior Vice President, Corporate Development
...ale of that company to Sanofi-Aventis in April of this year. Previously, he held senior corporate development, marketing, and strategy positions with allos Therapeutics, Connetics Corporation, Abgenix and Gilead Sciences. Mr. Patel also served as a consultant with McKinsey & Company. Earlier in his ...Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes
...SDAQ: ALXN ) ALKERMES INC. (NASDAQ: ALKS ) ALLERGAN INC. (NYSE: AGN ) allos THERAPEUTICS INC. (NASDAQ: ALTH ) ALNYLAM PHARMACEUTICALS INC. (NASDAQ: ...TM) Emerging Cancer Index (HHJ) Drop AETERNA ZENTARIS INC. (TSE: AEXS) allos THERAPEUTICS INC. (NASDAQ: ALTH ) ARQULE INC. (NASDAQ: ARQL ) ARRAY BIO...Allos Therapeutics to Present at the 2007 JMP Securities Healthcare Focus Conference
...be available for replay on Allos' website through November 27, 2007. About allos Therapeutics, Inc. allos Therapeutics is a biopharmaceutical company focused on the development and ...Three PDX (Pralatrexate) Studies Presented at the 2007 AACR-NCI-EORTC Conference
...s referenced above are available for review on the allos website (http://www.allos.com ) under the "Presen...Investor Relations" section of the website. About allos Therapeutics, Inc. allos Therapeutics, Inc. (ALTH) is a biopharmaceutical c...Allos Therapeutics to Present at the 2007 UBS Global Life Sciences Conference
... be available for replay on Allos' website through October 12, 2007. About allos Therapeutics, Inc. allos Therapeutics is a biopharmaceutical company focused on the development and ...Allos Therapeutics to Present at the Bear Stearns 20th Annual Healthcare Conference
...e available for replay on Allos' website through September 21, 2007. About allos Therapeutics, Inc. allos Therapeutics is a biopharmaceutical company focused on the development and ...